Saatja: HAGEBRO, Krystyna <
[email protected]>
Saadetud: 31.03.2021 18:04
Adressaat: Elen Ohov <
[email protected]>
Koopia: Triin Uusberg <
[email protected]>; SM Info <
[email protected]>;
<
[email protected]>; <
[email protected]>; <
[email protected]>;
<
[email protected]>; KÖHLER, Kristina <
[email protected]>
Teema: National Influenza Centre recognition status 2020/2021
Dear Ms Ohov,
On behalf of Dr Dorit Nitzan, Regional Emergency Director, please find
attached the letter confirming the recognition status of the NIC in your
country.
Sincerely,
Health Emergencies Programme
WHO Regional Office for Europe
WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION Date: 31 March 2021
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONAL OFFICE FOR EUROPE Ms Elen Ohov
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co-
Head office:
operation Department
UN City, Marmorvej 51, Ministry of Social Affairs
DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected] 10122 Tallinn
Website: http://www.euro.who.int Estonia
Our reference: Your reference:
Notre référence: Votre référence:
Unser Zeichen: Ihr Zeichen:
См. наш номер: На Ваш номер:
Dear Ms Ohov,
Based on a review of the performance of the National Influenza Centres (NICs) in the WHO European
Region during the 2018/2019 and 2019/2020 influenza seasons, I am pleased to inform you that the
WHO-recognized NIC in Estonia headed by Dr Natalja Kuznetsova at the Laboratory for
Communicable Diseases meets the criteria and will continue to be recognized by WHO.
NICs play a key role in influenza (sentinel) surveillance at the national level and contribute to regional
and global surveillance through the Global Influenza Surveillance and Response System (GISRS).
The data generated by the NICs are critical to understanding the timing and spread of influenza
epidemics and the contribution of different viruses to morbidity and mortality. For the WHO European
Region, the data are reported weekly in the Flu News Europe bulletin jointly produced by the WHO
Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC).
According to the Terms of Reference (ToR), NICs are requested to share representative seasonal
influenza viruses (either positive samples or influenza virus isolates) by shipping them to a WHO
Collaborating Centre (WHO CC) for Reference and Research on Influenza. Characterization of these
viruses collected from the whole GISRS network contributes to the biannual selection of viruses for
seasonal influenza vaccines and to the monitoring of susceptibility to antiviral drugs.
In compliance with the Standard Material Transfer Agreement of the Pandemic Influenza Preparedness
(PIP) Framework, NICs are also requested to send emerging influenza viruses with pandemic potential
as well as clinical specimens and/or viruses that cannot be readily identified with diagnostic reagents to
a WHO CC or WHO H5 Reference Laboratory of their choice.
In addition, NICs should regularly assess their competencies by taking part in External Quality
Assessment Programmes (EQAPs), in particular the annual EQAP organized by the WHO Global
Influenza Programme with the Centre for Health Protection in Hong Kong SAR (China).
The pandemic of COVID-19 that started in early 2020 has clearly affected the normal functioning of
influenza surveillance systems and the work of the NIC across the countries of the European Region
during the 2020/2021 season. The 2021/2022 influenza season will also be difficult, but the sentinel
surveillance systems should be maintained as they will prove to be essential tools when the pandemic
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int
Denmark
phase of SARS-CoV-2 ultimately ends, and in the eventuality that SARS-CoV-2 becomes a seasonal
virus.
It is thus of paramount importance that, as the Ministry of Health, you continue to support the NIC in
your country so that it can fulfil its missions within the WHO NIC ToR and further strengthen the
epidemiological and virological surveillance of seasonal and emerging influenza viruses and other
respiratory viruses of public health concern.
WHO will of course continue to support the NIC in your country by providing technical guidance,
training and networking opportunities.
I would like to warmly thank your country for collaborating so closely with WHO and I look forward
to its continuation.
Sincerely yours,
Dr Dorit Nitzan
Regional Emergency Director
Copy for information to:
Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs,
Suur-Ameerika 1, 10129 Tallinn, Estonia
H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative,
Permanent Mission of the Republic of Estonia to the United Nations Office and other international
organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland
H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of
Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia
–2–
Enclosure
Details of the National Influenza Centre in your country, status of WHO recognition
and key reference documents
NICs should demonstrate each year that they comply with the WHO NIC terms of reference.
Those NICs that do not meet the criteria will have one year to take corrective action, which will be
supported by WHO where possible.
Thank you for reviewing the NIC details below and for informing us of any changes.
1. NIC details
Natalja Kuznetsova
Laboratory for Communicable Diseases
Health Board Kotka Str 2
Tallinn 11315
Estonia
Fax: +372 6943 651
Status of WHO recognition in 2020/2021
Maintained: NIC meets the criteria
Provisionally maintained: NIC failed to meet all the criteria
2. Key reference materials:
1. How to become a WHO-recognized National Influenza Centre: Guidance on the process for influenza laboratories in the
WHO European Region [web site]. Copenhagen: WHO Regional Office for Europe; (http://www.euro.who.int/en/what-
we-do/health-topics/diseases-and-conditions/influenza/publications/2010/how-to-become-a-who-recognized-national-
influenza-centre-guidance-on-the-process-for-influenza-laboratories-in-the-who-european-region).
2. Terms of Reference for National Influenza Centres [web site]. Geneva: World Health Organization;
(http://www.who.int/influenza/gisn_laboratory/national_influenza_centres/terms_of_reference_for_national_influenza_ce
ntres.pdf).
3. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other
benefits. Geneva: World Health Organization; 2011 (http://www.who.int/influenza/pip/en/).
4. European Centre for Disease Prevention and Control/WHO Regional Office for Europe, Flu News Europe, joint weekly
influenza update; (http://flunewseurope.org/).
–3–